ASLAN Pharmaceuticals Limited
ASLN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $17,190 | $50,216 | $145,907 | $140,710 |
| - Cash | $21,252 | $56,902 | $90,168 | $14,324 |
| + Debt | $26,825 | $37,621 | $31,056 | $19,255 |
| Enterprise Value | $22,763 | $30,935 | $86,795 | $145,641 |
| Revenue | $12,000 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $11,652 | -$332 | -$282 | -$298 |
| % Margin | 97.1% | – | – | – |
| EBITDA | -$39,403 | -$47,276 | -$29,447 | -$15,426 |
| % Margin | -328.4% | – | – | – |
| Net Income | -$44,220 | -$51,382 | -$34,709 | -$17,906 |
| % Margin | -368.5% | – | – | – |
| EPS Diluted | -10.76 | -14.72 | -10.64 | -9.32 |
| % Growth | 26.9% | -38.3% | -14.2% | – |
| Operating Cash Flow | -$46,360 | -$38,405 | -$33,996 | -$15,053 |
| Capital Expenditures | -$11 | -$27 | -$49 | -$5 |
| Free Cash Flow | -$46,371 | -$38,432 | -$34,044 | -$15,058 |